Canvas Wealth Advisors LLC Sells 48 Shares of Intuitive Surgical, Inc. $ISRG

Canvas Wealth Advisors LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.5% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 457 shares of the medical equipment provider’s stock after selling 48 shares during the period. Canvas Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $248,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the period. GAMMA Investing LLC grew its position in shares of Intuitive Surgical by 9.3% in the 1st quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock worth $3,029,000 after buying an additional 518 shares during the period. Cambridge Investment Research Advisors Inc. increased its stake in shares of Intuitive Surgical by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 32,747 shares of the medical equipment provider’s stock worth $16,219,000 after acquiring an additional 1,480 shares in the last quarter. Duncker Streett & Co. Inc. purchased a new position in Intuitive Surgical during the 1st quarter valued at about $1,369,000. Finally, Flagship Harbor Advisors LLC boosted its stake in Intuitive Surgical by 4.8% during the first quarter. Flagship Harbor Advisors LLC now owns 3,316 shares of the medical equipment provider’s stock worth $1,642,000 after acquiring an additional 151 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares in the company, valued at $504,898.14. This represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $458.47 on Tuesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business’s fifty day moving average is $454.70 and its 200 day moving average is $495.81. The stock has a market capitalization of $164.35 billion, a PE ratio of 63.94, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical’s revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.78 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on ISRG. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Piper Sandler reissued an “overweight” rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company increased their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Finally, Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $580.29.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.